Literature DB >> 21208514

Prevalence of markers for HIV, hepatitis B and hepatitis C infection in UK military recruits.

A E Brown1, D A Ross, A J H Simpson, R S Erskine, G Murphy, J V Parry, O N Gill.   

Abstract

An unlinked anonymous survey was conducted to measure the prevalence of selected markers for HIV, hepatitis B and C infection in recruits to the UK Armed Forces to inform future screening and hepatitis B vaccination policies. During 2007, nearly 14 000 left-over samples taken from new recruits for blood typing were collected, unlinked from identifiers and anonymously tested for HIV, hepatitis C and current and past cleared hepatitis B infection. Overall, serological evidence of HIV and hepatitis C was found in 0·06% and 0·06% of recruits, respectively. Evidence of past cleared and current hepatitis B infection was found in 3·63% and 0·37% of recruits, respectively. Overall, prevalence rates were broadly consistent with UK population estimates of infection. However, HIV and hepatitis B prevalence was higher in recruits of African origin than in those from the UK (P<0·0001). Screening for these infections is an option that could be considered for those entering Services from high-prevalence countries.

Entities:  

Mesh:

Year:  2011        PMID: 21208514     DOI: 10.1017/S0950268810002712

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  HIV/STI prevalence study among military conscripts in Estonia.

Authors:  R David Parker; Michael Regier; Joseph Widmeyer; Kristi Rüütel
Journal:  J Community Health       Date:  2015-04

2.  HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Authors:  R Ranjbar; A Davari; M Izadi; N Jonaidi; S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

3.  Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India.

Authors:  Jayeeta Sarkar; Debraj Saha; Bhaswati Bandyopadhyay; Bibhuti Saha; Deepika Kedia; D N Guha Mazumder; Runu Chakravarty; Subhasish Kamal Guha
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

Review 4.  Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Authors:  Jeffrey V Lazarus; Ida Sperle; Alexander Spina; Jürgen K Rockstroh
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

5.  Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank.

Authors:  Alexander J Mentzer; Nicole Brenner; Naomi Allen; Thomas J Littlejohns; Amanda Y Chong; Adrian Cortes; Rachael Almond; Michael Hill; Simon Sheard; Gil McVean; Rory Collins; Adrian V S Hill; Tim Waterboer
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 14.919

6.  Cross-sectional assessment of prevalence and correlates of blood-borne and sexually-transmitted infections among Afghan National Army recruits.

Authors:  Catherine S Todd; Abdul Nasir; G Farooq Mansoor; Sayed M Sahibzada; Linda L Jagodzinski; Farzana Salimi; M Naim Khateri; Braden R Hale; R Vincent Barthel; Paul T Scott
Journal:  BMC Infect Dis       Date:  2012-08-21       Impact factor: 3.090

7.  Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers.

Authors:  Abbasali Javadi; Behrooz Ataei; Nazila Kassaian; Zary Nokhodian; Majid Yaran
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.